CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Oncosem Onkolojik Sistemlr Sny v Tcrt AS is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Oncosem Onkolojik Sistemlr Sny v Tcrt AS
Mutlukent Mh. 1988 Cd. No: 12 Cankaya
ANKARA, 06510  Turkey Ticker: ONCSM.EONCSM.E

Business Summary
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is a Turkey-based company, which is engaged in the production of medical devices. The Company manufactures electromedical and electrotherapeutic apparatus, surgical and medical instruments, and other related medical products. Oncosem Onkolojik Sistemler is specialized in the manufacturing of equipment and medical devices used in cancer treatment, and it offers fully automated chemotherapy drug preparation devices, diagnostic tests and protective equipment, and waste collection devices. The Company also manufactures hazardous waste sealing systems, chemotherapy preparation and administration consumables, Oncosem devices' components, and infusion pumps.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023-----

General Information
Number of Employees: 324 (As of 12/31/2023)
Outstanding Shares: 23,850,000 (As of 12/31/2023)
Stock Exchange: IST


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024